出版國家:England
出版周期:雙月刊
影響因子:3.873
研究領域:生物工程醫(yī)學
5年影響因子:3.784
國外數據庫收錄:IM,3.873" />
醫(yī)學全在線
醫(yī)學全在線首頁-醫(yī)師-藥師-護士-衛(wèi)生資格-高級職稱-考試題庫-網校-考研-圖譜-下載-招聘  
分類
國家級省級浙江省各省雜志
科技核心北大核心CSCDCSCD擴展
工具
期刊知識寫作指導 論文投稿推薦期刊
期刊驗證論文檢測 錄用通知往期目錄
SCI
SCI指導影響因子
期刊點評基金動態(tài)
其它
經濟教育計算機
建筑體育農業(yè)
北京|天津|河北|山西|湖北|江蘇|安徽|山東|上海|浙江|江西|福建|湖南|寧夏|內蒙古|河南
四川|重慶|貴州|云南|遼寧|吉林|廣東|廣西|海南|陜西|甘肅|新疆|青海|衛(wèi)生部直屬|黑龍江|兵團
您現在的位置: 醫(yī)學全在線 > 醫(yī)學論文 > SCI期刊 > 正文:Regenerative Medicine if:3.873
    

Regenerative Medicine


Regenerative Medicine
影響因子: 3.873
I S S N: 1746-0751
出 版 社: London
出 版 地: Future Medicine Ltd.
出版國家: England
刊  期: 雙月刊
創(chuàng)刊時間: 2006
語  種: 英文
審稿周期: 較慢,6-12周
中科院分區(qū): 2
投稿命中率: 一般
國外數據庫收錄: IM
中國收錄文章數: 8
5年影響因子: 3.784
研究領域: 生物工程醫(yī)學
官方鏈接: http://www.futuremedicine.com/loi/rme
投稿須知: http://www.futuremedicine.com/loi/rme

期刊介紹:

Improved healthcare has resulted in dramatic demographic changes in developed countries, causing an increase in the prevalence of diseases associated with aging. Many significant human diseases arising from the loss or dysfunction of specific cell types in the body, such as Parkinson's disease, diabetes and cancer, are becoming increasingly common. Stem cell research and regenerative medicine offers unique opportunities for developing new therapeutic approaches to prevent and treat these debilitating and life-threatening diseases, and new ways to explore fundamental questions of biology. The current optimism over potential stem cell therapies is driven by new understandings of genetics and developmental biology. Gradually, the curative and regenerative potential that lies in harnessing stem cells is being realized. Regenerative Medicine (ISSN: 1746-0751) provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to an increasingly time-constrained community.
...
關于我們 - 聯系我們 -版權申明 -誠聘英才 - 網站地圖 - 網絡課程 - 幫助
醫(yī)學全在線 版權所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP備12017320號
百度大聯盟認證綠色會員實名網站 360認證可信網站 中網驗證